dr. jeffrey weber on checkmate-064 trial for advanced melanoma
Published 8 years ago • 364 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:05
dr. jeffrey weber explores nivolumab in advanced melanoma
-
2:10
dr. jeffrey s. weber on why the results of checkmate-064 were surprising
-
1:44
dr. jeffrey weber on optimal therapy sequences in advanced melanoma
-
1:17
dr. weber on checkmate-238 compared to other trials in melanoma
-
1:22
dr. weber on nivolumab versus chemotherapy in advanced melanoma
-
1:55
dr. jeffrey weber on ipilimumab for melanoma
-
0:56
dr. weber on checkmate-238 for melanoma
-
1:05
dr. weber on rationale for the checkmate-238 trial in melanoma
-
1:15
dr. weber on nivolumab in the adjuvant setting for melanoma
-
1:42
dr. weber on biomarker data from checkmate-238 for melanoma
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
2:26
jeffrey weber, md, phd explains the long term data from keynote-001 study in advanced melanoma
-
5:30
jeffrey s weber, asco 2018 – resected stage iii melanoma and the checkmate 238 trial
-
1:13
clinical trials investigating the treatment of melanoma
-
2:01
checkmate 172 trial of nivolumab for advanced melanoma: preliminary results
-
1:28
jeffrey weber, md, phd: the impact of braf/mek inhibitors in melanoma
-
1:21
dr. jeffrey weber on potential breakthrough "cures" in melanoma
-
7:34
adjuvant therapy for melanoma: nivolumab, pembrolizumab, ipilimumab, dabrafenib and trametinib
-
2:21
meet oncologist dr. jeffrey weber